Analyst Consensus ?
ConsensusHold22 ratings
Bullish1045.5%
Neutral1045.4%
Bearish29.1%
FN2 Earnings Intelligence
Ameriprise Financial, Inc. analyst ratings
Ameriprise Financial, Inc. (AMP) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$492.85Current
$330Low
$509.11Average
$645High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| B of A Securities | Underperform | Buy | Downgrade | Oct 19, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Oct 9, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 7, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Oct 6, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 31, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 24, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 24, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jul 13, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 10, 2026 |
| William Blair | Market Perform | Outperform | Downgrade | Jul 25, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 25, 2025 |
| UBS | Neutral | Buy | Downgrade | Jan 6, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 27, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 1, 2023 |
| Citigroup | Buy | Buy | Maintain | Jun 21, 2021 |
| Barclays | Overweight | Overweight | Maintain | Apr 12, 2021 |
| CFRA | Buy | Buy | Maintain | May 13, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Oct 26, 2017 |
| Deutsche Bank | Hold | Buy | Downgrade | Oct 14, 2016 |
| Wells Fargo | Market Perform | Outperform | Downgrade | Jan 13, 2016 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Oct 12, 2015 |
| Sterne Agee | Neutral | Neutral | Maintain | Oct 13, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $492.85. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $483 | $499.08 | -2.0% | Oct 9, 2026 |
| Capital One Financial | Brennan Hawken | $520 | $496.67 | +5.5% | Oct 6, 2026 |
| Raymond James | Analyst unavailable | $570 | $490.91 | +15.7% | Oct 5, 2026 |
| Raymond James | Analyst unavailable | $638 | $558.26 | +29.5% | Aug 21, 2026 |
| Piper Sandler | Analyst unavailable | $518 | $506.76 | +5.1% | Jul 13, 2026 |
| Morgan Stanley | Michael Cyprys | $489 | $506.62 | -0.8% | Jul 10, 2026 |
| Jefferies | Suneet Kamath | $645 | $500.16 | +30.9% | Jul 10, 2026 |
| Piper Sandler | Crispin Love | $471 | $467.19 | -4.4% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $467 | $479.63 | -5.2% | Apr 30, 2026 |
| BMO Capital | Brennan Hawken | $490 | $455.71 | -0.6% | Apr 24, 2026 |
| RBC Capital | Analyst unavailable | $560 | $456.59 | +13.6% | Apr 21, 2026 |
| Morgan Stanley | Analyst unavailable | $452 | $441.86 | -8.3% | Apr 10, 2026 |
| Raymond James | Wilma Burdis | $582 | $488.19 | +18.1% | Feb 11, 2026 |
| RBC Capital | Kenneth Lee | $605 | $529.47 | +22.8% | Feb 2, 2026 |
| Piper Sandler | John Barnidge | $530 | $521.36 | +7.5% | Jan 29, 2026 |
| Morgan Stanley | Analyst unavailable | $485 | $489.17 | -1.6% | Dec 22, 2025 |
| Evercore ISI | Analyst unavailable | $570 | $490.17 | +15.7% | Oct 9, 2025 |
| Morgan Stanley | Analyst unavailable | $484 | $486.62 | -1.8% | Oct 1, 2025 |
| Morgan Stanley | Michael Cyprys | $462 | $519.55 | -6.3% | May 15, 2025 |
| Morgan Stanley | Michael Cyprys | $509 | $514.04 | +3.3% | Oct 30, 2024 |
| Goldman Sachs | Alexander Blostein | $476 | $463.09 | -3.4% | Sep 25, 2024 |
| RBC Capital | Kenneth Lee | $500 | $432.05 | +1.5% | Jul 30, 2024 |
| UBS | Brennan Hawken | $495 | $429.25 | +0.4% | Jul 9, 2024 |
| Argus Research | Kevin Heal | $460 | $418.95 | -6.7% | May 6, 2024 |
| Morgan Stanley | Michael Cyprys | $445 | $412.86 | -9.7% | Apr 24, 2024 |
| Morgan Stanley | Michael Cyprys | $437 | $435.77 | -11.3% | Apr 9, 2024 |
| Piper Sandler | John Barnidge | $392 | $428.89 | -20.5% | Apr 5, 2024 |
| Morgan Stanley | Analyst unavailable | $345 | $320.45 | -30.0% | Jan 10, 2023 |
| UBS | Analyst unavailable | $370 | $324.71 | -24.9% | Jan 9, 2023 |
| Goldman Sachs | Analyst unavailable | $330 | $332.97 | -33.0% | Nov 23, 2022 |
| Morgan Stanley | Analyst unavailable | $340 | $316.94 | -31.0% | Nov 17, 2022 |
| Piper Sandler | Analyst unavailable | $220 | $223.12 | -55.4% | Jul 15, 2022 |
| Piper Sandler | Analyst unavailable | $231 | $238.27 | -53.1% | Jul 8, 2022 |
| Piper Sandler | John Barnidge | $253 | $235.1 | -48.7% | Jun 21, 2022 |
| Piper Sandler | Analyst unavailable | $275 | $274.33 | -44.2% | May 27, 2022 |
| UBS | Analyst unavailable | $350 | $267.4 | -29.0% | Apr 26, 2022 |
| Morgan Stanley | Analyst unavailable | $330 | $280.96 | -33.0% | Apr 26, 2022 |
| Jefferies | Suneet Kamath | $350 | $293.04 | -29.0% | Apr 9, 2022 |
| Piper Sandler | John Barnidge | $310 | $292.26 | -37.1% | Apr 6, 2022 |
Track every rating change on AMP the moment it posts. Free to start.
Start freeGet the AMP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.